Page last updated: 2024-08-23

staurosporine and mebendazole

staurosporine has been researched along with mebendazole in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assefnia, S; Brown, ML; Byers, SW; Dakshanamurthy, S; Issa, NT; Madhavan, S; Peters, OJ; Seshasayee, A; Uren, A	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1

Other Studies

2 other study(ies) available for staurosporine and mebendazole

Article	Year
Predicting new indications for approved drugs using a proteochemometric method. Journal of medicinal chemistry, 2012, Aug-09, Volume: 55, Issue:15 Topics: Animals; Antineoplastic Agents; Antirheumatic Agents; Cadherins; Celecoxib; Cell Line, Tumor; Crystallography, X-Ray; Databases, Factual; Drug Discovery; Drug Repositioning; Drugs, Investigational; Human Umbilical Vein Endothelial Cells; Humans; Mebendazole; Mice; Models, Molecular; Neovascularization, Pathologic; Pharmaceutical Preparations; Protein Binding; Protein Conformation; Proteins; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor Receptor-2	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013

Article

Year

Predicting new indications for approved drugs using a proteochemometric method.

Journal of medicinal chemistry, 2012, Aug-09, Volume: 55, Issue:15

Topics: Animals; Antineoplastic Agents; Antirheumatic Agents; Cadherins; Celecoxib; Cell Line, Tumor; Crystallography, X-Ray; Databases, Factual; Drug Discovery; Drug Repositioning; Drugs, Investigational; Human Umbilical Vein Endothelial Cells; Humans; Mebendazole; Mice; Models, Molecular; Neovascularization, Pathologic; Pharmaceutical Preparations; Protein Binding; Protein Conformation; Proteins; Pyrazoles; Sulfonamides; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor Receptor-2

2012

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013